Stryker Neurovascular
Active in EUDAMEDUnited Statesfrom SRN EUDAMED FDA SRN US-MF-000002456 FEI 3012931345
- Devices
- 70
- Registrations
- EUDAMEDFDA
- FDA recalls
- 10915 ongoing
At a glance
EU certificates
8 of 8 in force.
Market reach
- European Union
- EUDAMED actor, 8 certificates
- United States
- FDA establishment, FDA recalls
Catalogue
Search and filter all 70 devicesShowing 1-50 of 70
Company details
- EUDAMED SRN
- US-MF-000002456
- FDA FEI number
- 3012931345
- EU VAT number
- IE9771305F
- EUDAMED status
- Active
- EUDAMED registered name
- Stryker Neurovascular
- EUDAMED abbreviated name
- SNV
- Registered address
- 47900, Bayside Parkway, 94538, Fremont, United States
- Website
- www.stryker.com/
- [email protected]
- Phone
- +1 510 413 2500
- PRRC contact
- Tara Lopez
EUDAMED certificates
8 certificates8 valid, 0 expiredMDR 8next expiry 16 Nov 2026
BSI Group The Netherlands B.V. 2797 8 certificates
- MDR 728401 Active
Quality management system EU MDR
- Issued
- 18 Sep 2026
- Expires
- 16 Nov 2031
- Valid from
- 17 Nov 2026
- MDR 829526 Active
Technical documentation EU MDR
- Issued
- 25 Jun 2026
- Expires
- 24 Jun 2031
- MDR 739951 Active
Technical documentation EU MDR
- Issued
- 27 Feb 2024
- Expires
- 23 May 2028
- Reason
- Other
- MDR 736172 Active
Technical documentation EU MDR
- Issued
- 2 Mar 2023
- Expires
- 1 Mar 2028
- MDR 736166 Expiring
Technical documentation EU MDR
- Issued
- 15 Oct 2022
- Expires
- 14 Oct 2027
- MDR 736168 Expiring
Technical documentation EU MDR
- Issued
- 23 Dec 2023
- Expires
- 14 Oct 2027
- Reason
- Other
- MDR 737645 Expiring
Technical documentation EU MDR
- Issued
- 15 Oct 2022
- Expires
- 14 Oct 2027
- MDR 728401 Expiring
Quality management system EU MDR
- Issued
- 25 Jun 2026
- Expires
- 16 Nov 2026
- Reason
- Add device or group
FDA recalls
Recalls initiated per year
- 2017 8
- 2018 12
- 2019 3
- 2020 1
- 2021 0
- 2022 1
- 2023 0
- 2024 13
- 2025 0
- 2026 1
2026
- 6 Apr 2026 Z-2552-2026 Class II Ongoing Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative technique.
Full distribution text
- 6 Apr 2026 Z-2552-2026 Class II Ongoing Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative technique.
2024
- 30 Aug 2024 Z-0021-2025 Class II Ongoing Stryker Neurovascular has observed that devices with Out of United States (OUS) approved Instructions for Use (IFU) and Packaging Labels (pouch and carton), different configurations, have been erroneously distributed to customers in the US.
- 23 Apr 2024 Z-1902-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1903-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1904-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1905-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1906-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1907-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1908-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
- 23 Apr 2024 Z-1909-2024 Class II Ongoing Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Full distribution text
Show the 25 most recent of 109 recalls
2024
- 18 Apr 2024 Z-1939-2024 Class II Ongoing Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Full distribution text
- 18 Apr 2024 Z-1940-2024 Class II Ongoing Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Full distribution text
- 18 Apr 2024 Z-1941-2024 Class II Ongoing Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Full distribution text
- 3 Apr 2024 Z-1740-2024 Class II Ongoing Stryker Neurovascular is recalling their DAC- Distal Access Catheter -038 136cm, a Distal Access Catheter by removal. The reason for the recall is: the DAC Lot #0000486382 was released with out-of-specification endotoxin results.
- 18 Apr 2024 Z-1939-2024 Class II Ongoing Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
2022
- 3 Jun 2022 Z-1386-2022 Class II Ongoing Microcatheter product label on the carton is missing the microcatheter product drawing/illustration.
Full distribution text
- 3 Jun 2022 Z-1386-2022 Class II Ongoing Microcatheter product label on the carton is missing the microcatheter product drawing/illustration.
2020
- 21 Sep 2020 Z-0114-2021 Class I Terminated Increase in fracture complaints of the flexible, tapered core wire, resulting in stent retriever separation from the core wire during use. The stent retriever can be left behind in the vasculature.
Full distribution text
- 21 Sep 2020 Z-0114-2021 Class I Terminated Increase in fracture complaints of the flexible, tapered core wire, resulting in stent retriever separation from the core wire during use. The stent retriever can be left behind in the vasculature.
2019
- 18 Apr 2019 Z-1708-2019 Class II Terminated A design related issue can contribute to the device exhibiting brittle behavior. This behavior may result in fractures of the catheter shaft.
Full distribution text
- 10 Apr 2019 Z-1620-2020 Class II Terminated The firm has become aware of a potential problem that their Catheters may break/fracture and/or kink/bend if improperly removed from the packaging/dispenser hoop or during catheter use.
Full distribution text
- 10 Apr 2019 Z-1621-2020 Class II Terminated The firm has become aware of a potential problem that their Catheters may break/fracture and/or kink/bend if improperly removed from the packaging/dispenser hoop or during catheter use.
Full distribution text
- 18 Apr 2019 Z-1708-2019 Class II Terminated A design related issue can contribute to the device exhibiting brittle behavior. This behavior may result in fractures of the catheter shaft.
2018
- 13 Nov 2018 Z-0065-2020 Class II Terminated Labeling error; 8F Balloon Guide Catheters have been packaged within 9F Balloon Guide Catheter packaging
Full distribution text
- 8 Jun 2018 Z-0225-2020 Class II Terminated The product labels (pouch and carton) for products contain an incorrect value in millimeters (0.036mm) for the Guidewire Outer Diameter dimension. The inches dimension (0.014in) on the label is correct. The correct values are 0.014in (0.36mm). 0.036mm represents a typographical error.
Full distribution text
- 8 Jun 2018 Z-0226-2020 Class II Terminated The product labels (pouch and carton) for products contain an incorrect value in millimeters (0.036mm) for the Guidewire Outer Diameter dimension. The inches dimension (0.014in) on the label is correct. The correct values are 0.014in (0.36mm). 0.036mm represents a typographical error.
Full distribution text
- 8 Jun 2018 Z-0227-2020 Class II Terminated —
Full distribution text
- 8 Jun 2018 Z-0228-2020 Class II Terminated The product labels (pouch and carton) for products contain an incorrect value in millimeters (0.036mm) for the Guidewire Outer Diameter dimension. The inches dimension (0.014in) on the label is correct. The correct values are 0.014in (0.36mm). 0.036mm represents a typographical error.
Full distribution text
- 8 Jun 2018 Z-0229-2020 Class II Terminated The product labels (pouch and carton) for products contain an incorrect value in millimeters (0.036mm) for the Guidewire Outer Diameter dimension. The inches dimension (0.014in) on the label is correct. The correct values are 0.014in (0.36mm). 0.036mm represents a typographical error.
Full distribution text
- 13 Nov 2018 Z-0065-2020 Class II Terminated Labeling error; 8F Balloon Guide Catheters have been packaged within 9F Balloon Guide Catheter packaging
FDA establishments
- Stryker Neurovascular Cork Munster · IE FEI 3008881809
Frequently asked questions
How many devices does Stryker Neurovascular have in the registry?
The registry currently lists 70 devices for Stryker Neurovascular. Devices recorded under merged duplicate company entries are counted once.
Which registries list Stryker Neurovascular's devices?
Among its 50 most recently registered devices, Stryker Neurovascular has devices listed in EUDAMED (32 devices) and FDA 510(k) (18 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Stryker Neurovascular's devices fall under?
Among its 50 most recently registered devices, the classes recorded for Stryker Neurovascular's devices are Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for Stryker Neurovascular?
FDA recall records list 109 recalls initiated by Stryker Neurovascular, the most recent initiated on 6 Apr 2026. 15 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What EUDAMED certificates are recorded for Stryker Neurovascular?
EUDAMED lists 8 certificates for Stryker Neurovascular (quality management system; technical documentation) under MDR. 4 are recorded with the status issued. The most recent was issued on 18 Sep 2026.
What are the newest devices from Stryker Neurovascular in the registry?
The most recently registered devices listed for Stryker Neurovascular include Wingspan, AXS Catalyst 6, Trenza and AXS Catalyst 5.